A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful weight loss while simultaneously protecting the heart, kidneys, ...

In preclinical findings, the investigational new oral drug TIX100 completely prevented weight rebound in mouse models after semaglutide was stopped — a discovery that lays the groundwork for human ...

Share on Pinterest A new oral GLP-1 drug effectively lowers blood sugar, boosts weight loss in type 2 diabetes, according to recent trial data. Image credit: Yana Iskayeva/Getty Images About 12% of ...

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also ...

A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes ...

Eli Lilly’s Mounjaro (tirzepatide) delivered better blood sugar control and weight loss than other GLP-1 medications when added early in Type 2 diabetes treatment, according to a new study published ...

India, April 17 -- Approximately 10% of the population carries specific genetic variants that cause GLP-1 (Glucagon-like peptide-1) resistance, significantly reducing the effectiveness of popular Type ...